Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 11/20 | 0.44 |
| ▸ | FGFR3 | P22607 | 10/20 | 0.44 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.38 |
| ▸ | FLT3 | P36888 | 3/20 | 0.37 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3385600 | 0.85 | KDR (0.46) | KDRFGFR3CTSCNTRK1FLT3 | |
| SCHEMBL3385818 | 0.85 | KDR (0.49) | KDRFGFR3 | |
| SCHEMBL3382504 | 0.85 | KDR (0.47) | KDRFGFR3NTRK1FLT3 | |
| SCHEMBL3386120 | 0.84 | KDR (0.46) | KDRFGFR3CTSCNTRK1FLT3 | |
| SCHEMBL3385300 | 0.83 | KDR (0.44) | KDRFGFR3NTRK1FLT3 | |
| SCHEMBL3382941 | 0.83 | KDR (0.44) | KDRFGFR3CTSCNTRK1FLT3 | |
| SCHEMBL3382858 | 0.83 | GLS (0.44) | KDRFGFR3 | |
| SCHEMBL3381810 | 0.81 | CCNE1 (0.48) | KDRFGFR3CTSCFLT3 | |
| SCHEMBL3195990 | 0.79 | KDR (0.42) | KDRFGFR3CTSCNTRK1FLT3 | |
| SCHEMBL3383110 | 0.79 | RET (0.48) | KDRFGFR3NTRK1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101128461-B | Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors | LILLY CO ELI | 2010-12-22 | — | — | CN | disclosed |
| EP-1904494-B1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS | LILLY CO ELI (US) | 2010-12-01 | — | — | EP | disclosed |
| CN-101128461-A | Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors | LILLY CO ELI (US) | 2008-02-20 | — | — | CN | disclosed |